格雷夫斯病病程中促甲状腺素受体抗体（TSI）的测定。这是该疾病缓解和持续存在的可靠指标吗？ - Suppr

Suppr

超能文献

Determination of thyroid stimulating immunoglobulins (TSI) during the course of Graves' disease. A reliable indicator for remission and persistence of this disease?

作者信息

Schleusener H, Finke R, Kotulla P, Wenzel K W, Meinhold H, Roedler H D

出版信息

J Endocrinol Invest. 1978 Apr;1(2):155-61. doi: 10.1007/BF03350364.

DOI:10.1007/BF03350364

PMID:90689

Abstract

摘要

相似文献

Determination of thyroid stimulating immunoglobulins (TSI) during the course of Graves' disease. A reliable indicator for remission and persistence of this disease?格雷夫斯病病程中促甲状腺素受体抗体（TSI）的测定。这是该疾病缓解和持续存在的可靠指标吗？

J Endocrinol Invest. 1978 Apr;1(2):155-61. doi: 10.1007/BF03350364.

Circulating immune complexes and thyroid-stimulating immunoglobulins before, during, and after antithyroid drug therapy in patients with Graves' disease.格雷夫斯病患者在抗甲状腺药物治疗前、治疗期间及治疗后的循环免疫复合物和促甲状腺素受体抗体

Lancet. 1980 Jun 28;1(8183):1376-9. doi: 10.1016/s0140-6736(80)92652-5.

[Clinical usefulness of the assay of TSH-binding inhibitor immunoglobulins (TBII) in patients with Graves' disease: Effect of antithyroid drug treatment on TBII and prognosis].[促甲状腺激素结合抑制性免疫球蛋白（TBII）检测在格雷夫斯病患者中的临床应用：抗甲状腺药物治疗对TBII及预后的影响]

Kaku Igaku. 1983 Dec;20(10):1425-31.

Persistent Graves' hyperthyroidism despite rapid negative conversion of thyroid-stimulating hormone-binding inhibitory immunoglobulin assay results: a case report.尽管促甲状腺激素结合抑制性免疫球蛋白检测结果迅速转阴，但仍存在持续性格雷夫斯甲亢：一例报告

J Med Case Rep. 2017 Feb 6;11(1):32. doi: 10.1186/s13256-017-1214-6.

Differences between changes in serum thyrotropin-binding inhibitory antibodies and thyroid-stimulating antibodies in the course of antithyroid drug therapy for Graves' disease.格雷夫斯病抗甲状腺药物治疗过程中血清促甲状腺素结合抑制性抗体与促甲状腺抗体变化的差异。

Thyroid. 1999 Aug;9(8):769-73. doi: 10.1089/thy.1999.9.769.

Are pituitary and thyroid function tests useful for the monitoring of antithyroid drug treatment and the post therapeutic control of Graves' disease?垂体和甲状腺功能检查对监测抗甲状腺药物治疗及Graves病治疗后的控制是否有用？

Horm Res. 1987;26(1-4):137-45. doi: 10.1159/000180693.

Thyroid stimulating immunoglobulin in Graves' disease.格雷夫斯病中的促甲状腺素受体刺激性抗体

Aust N Z J Med. 1981 Jun;11(3):293-8.

Concentration of TSH-receptor antibodies (TBII) in the sera of patients with immunogenic hyperthyroidism (Graves' disease) receiving antithyroid medication.接受抗甲状腺药物治疗的免疫性甲状腺功能亢进症（格雷夫斯病）患者血清中促甲状腺激素受体抗体（TBII）的浓度。

Radiobiol Radiother (Berl). 1987;28(1):101-6.

J Clin Endocrinol Metab. 1984 Jan;58(1):62-9. doi: 10.1210/jcem-58-1-62.

Response to TRH, serum thyroid hormone concentration, and serum markers of autoimmunity after antithyroid therapy in Graves' disease.格雷夫斯病抗甲状腺治疗后对促甲状腺激素释放激素的反应、血清甲状腺激素浓度及自身免疫血清标志物

J Endocrinol Invest. 1978 Jan;1(1):9-16. doi: 10.1007/BF03346765.

引用本文的文献

Changes of circulating thyroid autoantibody levels during and after the therapy with methimazole in patients with Graves' disease.格雷夫斯病患者在服用甲巯咪唑治疗期间及治疗后的循环甲状腺自身抗体水平变化

J Endocrinol Invest. 1982 Jan-Feb;5(1):13-9. doi: 10.1007/BF03350476.

10 years experience with consecutive measurement of thyrotropin binding inhibiting antibodies (TBIAb).连续检测促甲状腺素结合抑制性抗体（TBIAb）的10年经验。

J Endocrinol Invest. 1984 Jun;7(3):215-20. doi: 10.1007/BF03348426.

The prognostic value of parallel measurements of thyrotropin binding inhibiting immunoglobulins (TBII) and thyroid adenylate cyclase stimulating antibodies (TSAb) in Graves' disease after longterm antithyroid treatment.长期抗甲状腺治疗后，促甲状腺素结合抑制性免疫球蛋白（TBII）与甲状腺腺苷酸环化酶刺激抗体（TSAb）平行检测在格雷夫斯病中的预后价值。

J Endocrinol Invest. 1983 Aug;6(4):259-62. doi: 10.1007/BF03347586.

Thyroid-stimulating antibodies in patients with long-term remission of Graves' hyperthyroidism.格雷夫斯甲亢长期缓解患者的促甲状腺素抗体

Klin Wochenschr. 1986 Oct 31;64(21):1097-100. doi: 10.1007/BF01726868.

Prognostic value of thyroid stimulating antibodies and TSH-binding inhibiting immunoglobulins in the follow-up of Graves' disease.促甲状腺素抗体和促甲状腺素结合抑制性免疫球蛋白在格雷夫斯病随访中的预后价值。

Klin Wochenschr. 1985 Dec 16;63(24):1247-52. doi: 10.1007/BF01738449.

Thyroglobulin, thyrotropin and thyrotropin binding inhibiting immunoglobulins assayed at the withdrawal of antithyroid drug therapy as predictors of relapse of Graves' disease within one year.在停用抗甲状腺药物治疗时检测甲状腺球蛋白、促甲状腺激素和促甲状腺激素结合抑制性免疫球蛋白，作为Graves病一年内复发的预测指标。

J Endocrinol Invest. 1989 Oct;12(9):589-95. doi: 10.1007/BF03350008.

Clinical applications of assays for thyrotropin-receptor antibodies in Graves' disease.促甲状腺素受体抗体检测在格雷夫斯病中的临床应用

CMAJ. 1986 May 15;134(10):1141-7.

Clinical course and thyroid stimulating hormone (TSH) receptor antibodies during surgical treatment of Graves' disease.格雷夫斯病手术治疗期间的临床病程及促甲状腺激素（TSH）受体抗体

World J Surg. 1992 Jul-Aug;16(4):647-52; discussion 652-3. doi: 10.1007/BF02067345.

Interference of thyroglobulin in TSab detection by radio-receptor assay.甲状腺球蛋白对放射受体分析法检测TSab的干扰。

J Endocrinol Invest. 1979 Apr-Jun;2(2):221-2. doi: 10.1007/BF03349318.

Successful treatment of exophthalmos and pretibial myxoedema with plasmapheresis.血浆置换成功治疗突眼和胫前黏液性水肿。

Br Med J. 1979 Feb 10;1(6160):374-6. doi: 10.1136/bmj.1.6160.374.

本文引用的文献

Protein measurement with the Folin phenol reagent.使用福林酚试剂进行蛋白质测定。

J Biol Chem. 1951 Nov;193(1):265-75.

Measurements by competitive binding radioassay of serum anti-microsomal and anti-thyroglobulin antibodies in Graves' disease and other thyroid disorders.采用竞争性结合放射分析法对格雷夫斯病及其他甲状腺疾病患者血清中的抗微粒体抗体和抗甲状腺球蛋白抗体进行检测。

J Clin Endocrinol Metab. 1971 Oct;33(4):688-98. doi: 10.1210/jcem-33-4-688.

Evidence of lower toxicity during thyroxine suppression after a single 3-mg L-thyroxine dose: comparison to the classical L-triiodothyronine test for thyroid suppressibility.单次3毫克左甲状腺素剂量甲状腺素抑制期间较低毒性的证据：与经典的三碘甲腺原氨酸甲状腺抑制试验的比较

J Clin Endocrinol Metab. 1974 May;38(5):902-5. doi: 10.1210/jcem-38-5-902.

Sequential assessment during drug treatment of thyrotoxicosis.甲状腺毒症药物治疗期间的序贯评估。

Clin Endocrinol (Oxf). 1973 Jan;2(1):43-50. doi: 10.1111/j.1365-2265.1973.tb03483.x.

The pathogenesis of Graves' disease and Hashimoto's thyroiditis.格雷夫斯病和桥本甲状腺炎的发病机制。

Clin Endocrinol (Oxf). 1974 Jul;3(3):239-61. doi: 10.1111/j.1365-2265.1974.tb01800.x.

Quantitative thyroid scanning: a reliable thyroid function test.定量甲状腺扫描：一种可靠的甲状腺功能测试。

Am J Roentgenol Radium Ther Nucl Med. 1974 Aug;121(4):705-13. doi: 10.2214/ajr.121.4.705.

Correlation between long-acting thyroid stimulator protector level and thyroid 131-I uptake in thyrotoxicosis.甲状腺毒症中长效甲状腺刺激物保护剂水平与甲状腺 131-I 摄取率的相关性

Br Med J. 1974 Apr 27;2(5912):199-201. doi: 10.1136/bmj.2.5912.199.

Binding of thyroid stimulators to thyroid membranes.甲状腺刺激素与甲状腺膜的结合。

FEBS Lett. 1974 Jun 15;42(3):301-4. doi: 10.1016/0014-5793(74)80751-9.

[TRH stimulation test with age and sex specific TSH response in normal subjects (authors' transl)].正常受试者中按年龄和性别特异性促甲状腺激素反应进行的促甲状腺激素释放激素刺激试验（作者译）

Klin Wochenschr. 1974 Aug 1;52(15):722-7. doi: 10.1007/BF01469335.

Long-acting thyroid stimulator and related factors.长效甲状腺刺激素及相关因素

Proc R Soc Med. 1975 Apr;68(4):252-3. doi: 10.1177/003591577506800429.

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型，支持多种主流文档格式。

立即体验